The analyst's commentary reflects careful consideration of Haleon's latest guidance and market conditions, particularly the ...

Haleon PLC HLN shares dropped 1.63% to £3.67 Tuesday, on what proved to be an all-around favorable trading session for the ...

Haleon's global business lead for the Pain Portfolio & Systemics shares key consumer health trends reshaping the healthcare ...

Jefferies reiterated its Buy rating on Haleon PLC (HLN:LN) (NYSE: HLN), maintaining a price target of GBP4.50. Currently ...

Shares of Haleon PLC HLN inched up 0.03% to £3.73 Monday, on what proved to be an all-around favorable trading session for ...

On Jan 15, Pfizer Inc. ( PFE, Financial) announced to sale of about 700 million ordinary shares of Haleon plc through a ...

She was previously the supplier's head of commercial excellence for Europe, Middle East, Africa & Latin America ...

The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from ...

In a report released today, Iain Simpson from Barclays maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...

LAHORE: Haleon, multinational company is establishing a Pain Management Institute in Lahore to carry out research ...

Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne toothpaste.Most ...

Haleon, a global leader in consumer health, has taken a revolutionizing step for pain management by launching the Haleon Pain ...